NCT01620216 2021-11-04
Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
OHSU Knight Cancer Institute
Phase 2 Terminated
Clinical Trials
1 trialsHas results × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Drug Screening Assays, Antitumor × Clear all